These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10418856)

  • 1. Insulin resistance and lipid metabolism.
    Howard BV
    Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia of the metabolic syndrome.
    Ruotolo G; Howard BV
    Curr Cardiol Rep; 2002 Nov; 4(6):494-500. PubMed ID: 12379172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyslipidemia in insulin resistance and its improvement by troglitazone].
    Yagi K; Mabuchi H
    Nihon Rinsho; 2000 Feb; 58(2):426-9. PubMed ID: 10707570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
    Ginsberg HN
    Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
    Mamo JC; Watts GF; Barrett PH; Smith D; James AP; Pal S
    Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E626-32. PubMed ID: 11500319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
    DeFronzo RA; Ferrannini E
    Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and treatment of the dyslipidemia of insulin resistance.
    Cohn G; Valdes G; Capuzzi DM
    Curr Cardiol Rep; 2001 Sep; 3(5):416-23. PubMed ID: 11504579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk continuum: implications of insulin resistance and diabetes.
    Hsueh WA; Law RE
    Am J Med; 1998 Jul; 105(1A):4S-14S. PubMed ID: 9707262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid disorders in diabetes.
    Goldberg RB
    Diabetes Care; 1981; 4(5):561-72. PubMed ID: 6751732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology of lipoproteins.
    Tulenko TN; Sumner AE
    J Nucl Cardiol; 2002; 9(6):638-49. PubMed ID: 12466789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
    Brunzell JD; Ayyobi AF
    Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.